Swedish stent maker Jomed plans market listing:
This article was originally published in Clinica
Jomed, a Swedish manufacturer of cardiac minimally-invasive devices, plans a stock market listing by 2000 that could value the company at up to Euro800 million ($862 million). It is believed the Helsingborg-based group will list in Frankfurt rather than Stockholm. In 1998, the company's sales grew by 68% to Euro25.5 million, while profits almost tripled to Euro6.1 million. Jomed has expanded rapidly since its launch in the early 1990s, reflecting the corresponding growth in minimally-invasive surgery in the hospital sector.